Palace says Sinovac has been proven safe and effective

  • Presidential spokesperson Harry Roque said that based on clinical trials, Sinovac is effective and safe
  • He called out the critics to be silent and stop spreading fear against the China-made vaccine
  • Roque disclosed that even Indonesia and Thailand signed deals to procure Sinovac

Malacañang has assured that based on studies, the controversial China-made COVID-19 vaccine Sinovac has been proven to be safe and effective.

Image by Harry Roque via Facebook

Presidential spokesperson Harry Roque disclosed that based on the results from late-stage clinical trials of the CoronaVac in Turkey that it was 91.25% effective.

“There’s nothing spectacular about Sinovac other than it’s proven safe and efficient—91.5% (efficacy rate) in at least 3 jurisdictions that we know of,” Roque said.

“At maski kung tanungin ang mga eksperto, ang mga vaccinologist eh inactivated po iyan ibig sabihin natural. Ito po ay pinahinang virus, which are the traditional vaccines that we have known for the past 300 years,” he added.

Image by Harry Roque via Facebook

Roque even added that neighboring countries such as Indonesia and Thailand are also confident with Sinovac as they already closed deals to procure the vaccines.

The spokesperson also issued a lengthy tirade against those who are giving criticisms against the China-made vaccine. He brushed them as mere propaganda from the opposition to spread fear against Sinovac.

“Kinakalat po ng ating mga kalaban na matakot dapat sa mga vaccine ng Tsino, na kinakailangan western brands lang. Kaya pinapakita po natin na ang Tsino po ay dumaan sa clinical trials sa iba’t ibang bansa at at least [91.25%] ang efficacy rate po ng Sinovac,” he said.

“Manahimik na kayo. Puputok na naman iyan sa mga mukha ninyo. ‘Pag nag-survey na naman, kulelat na naman kayo, bokya na naman kayo, failure na naman kayo,” Roque was quoted by GMA saying.

Earlier, Health Secretary Francisco Duque III announced that the Philippines has secured 25 million doses of Sinovac. The first batch is expected to arrive in February.

Source :

GMA, Inquirer